Author Archive for: jmanz
About Jodi Manz
Jodi Manz joined NASHP in August 2019 as the project director with the Chronic and Vulnerable Populations Team, working on a variety of behavioral health and chronic care policy issues. Previously, she served as Assistant Secretary of Health and Human Resources for Virginia, first under Gov. Terry McAuliffe and then under Gov. Ralph Northam. She has a BA in religious studies and a Masters in social work administration, planning, and public policy, both from Virginia Commonwealth University.
Entries by Jodi Manz
As drug overdose fatalities continue to rise and incarceration rates remain high nationwide despite recent declines, states are increasingly developing opportunities for incarcerated individuals to access evidence-based opioid use disorder (OUD) treatment in state prison facilities. While the forced abstinence during incarceration can temporarily pause substance use itself, providing comprehensive treatment that includes medications for […]
The National Academy for State Health Policy (NASHP) recently spoke to Robert Hansen, executive director of West Virginia’s Office of Drug Control Policy, to learn how the state is expanding opioid use disorder (OUD) treatment access and capacity through strategic partnerships that support its Substance Use Response Plan’s goals. West Virginia has made expanding access […]
People with substance use disorders (SUD) who are experiencing housing instability or homelessness are particularly at risk during the COVID-19 pandemic, leaving states challenged more than ever to identify effective housing strategies that can simultaneously address the complex treatment needs of people with SUD while also curbing the spread of COVID-19 in congregate settings.
During the COVID-19 pandemic, the opioid epidemic has quietly raged on, requiring states to fight a costly, two-front war. While states have rallied to ensure that opioid use disorder (OUD) treatment remains accessible, organizational and workforce challenges persist and the resources and revenue needed to address them are rapidly changing. Gaps in treatment infrastructure and […]
In response to an increase in HIV and hepatitis C virus (HCV) infections in individuals with substance use disorders (SUD), including opioid use disorders (OUD), state policymakers are employing multifaceted strategies to address this syndemic, collaborating with public and private partners to prevent the spread of infectious disease and provide access to evidence-based treatment. This report […]
States are turning to telehealth to minimize direct contact between patients, providers, and other staff during the COVID-19 pandemic. For opioid use disorder (OUD) treatment, this shift represents a significant departure from how these services have been historically delivered and requires rapid organizational changes.
As coronavirus (COVID-19) cases increase exponentially and containment measures expand across the country, another public health emergency – the opioid use disorder (OUD) crisis – continues to rage. For individuals in treatment for OUD and those who provide them, COVID-19 presents a new set of barriers that make accessing these critical services challenging.
Since 2017, the federal government has awarded $2 billion to states specifically for opioid prevention, treatment, and recovery. But a new spending package passed last month allows states to use federal funds to address the growing use of stimulants, including cocaine and methamphetamine, that are emerging as the newest wave of drugs fueling the overdose […]
Corrections-involved populations have higher rates of opioid and substance use disorders (SUD) than the general population, with more than 75 percent of recently released individuals reporting an SUD or a chronic medical and/or psychiatric condition. These individuals face numerous barriers to receiving treatment, including stigma, limited access to medication-assisted treatment (MAT), and disconnected systems of […]